
'''Epithelial-myoepithelial carcinoma of the lung''' (EMECL) is a very rare [[histology|histologic]] form of [[malignant]] [[epithelial]] [[neoplasm]] ("carcinoma") arising from lung tissue.<ref name='who2004'>{{cite book |title=Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart |editor1-last=Travis |editor1-first=William D |editor2-last=Brambilla |editor2-first=Elisabeth |editor3-last=Muller-Hermelink |editor3-first=H Konrad |editor4-last=Harris |editor4-first=Curtis C |publisher=IARC Press |location=Lyon |year=2004 |series=World Health Organization Classification of Tumours |isbn=92 832 2418 3 |url=http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-cover.pdf |accessdate=27 March 2010}}</ref>

==Synonyms==
A number of now-obsolete terms have been used to describe EMECL in past literature,<ref name='who2004'/> including adenomyoepithelioma,<ref name='TsujiTateishi'>{{cite journal |author=Tsuji N, Tateishi R, Ishiguro S, Terao T, Higashiyama M |title=Adenomyoepithelioma of the lung |journal=Am. J. Surg. Pathol. |volume=19 |issue=8 |pages=956–62 |year=1995 |month=August |pmid=7611543 }}</ref> myoepithelioma, epithelial-myoepithelial tumor, epimyoepithelial carcinoma, and malignant mixed tumor containing epithelial and myoepithelial cells.<ref name='who2004'/>

==Classification==
[[Lung cancer]] is an extremely [[heterogeneous]] family of malignant [[neoplasm]]s,<ref name='RoggliVollmer'>{{cite journal |author=Roggli VL, Vollmer RT, Greenberg SD, McGavran MH, Spjut HJ, Yesner R |title=Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases |journal=Hum. Pathol. |volume=16 |issue=6 |pages=569–79 |year=1985 |month=June |pmid=2987102 |doi=10.1016/S0046-8177(85)80106-4}}
</ref> with well over 50 different [[histological]] variants recognized under the 4th revision of the [[World Health Organization]] (WHO) typing system ("WHO-2004"),<ref name="who2004"/> currently the most widely used lung cancer classification scheme. Because these variants have differing genetic, biological, and clinical properties, including response to treatment, correct classification of lung cancer cases are necessary to assure that lung cancer patients receive optimum management.<ref name="who2004"/><ref name='RossiMarchioni'>{{cite journal |author=Rossi G, Marchioni A, Sartori1 G, Longo L, Piccinini S, Cavazza A |title=Histotype in non-small cell lung cancer therapy and staging: The emerging role of an old and underrated factor |journal=Curr Resp Med Rev |volume=3 |pages=69–77 |year=2007 |doi=10.2174/157339807779941820 |url=http://www.ingentaconnect.com/content/ben/crmr/2007/00000003/00000001/art00011}}</ref><ref name='Vincent'>{{cite journal |author=Vincent MD |title=Optimizing the management of advanced non-small-cell lung cancer: a personal view |journal=Curr Oncol |volume=16 |issue=4 |pages=9–21 |year=2009 |month=August |pmid=19672420 |pmc=2722061 |url=http://www.current-oncology.com/index.php/oncology/article/view/465/374; |doi=10.3747/co.v16i4.465}}</ref>

The WHO-2004 scheme groups lung carcinomas into 8 major types:<ref name="who2004"/>

*[[Squamous cell carcinoma of lung|Squamous cell carcinoma]]
*[[Small cell carcinoma]]
*[[Adenocarcinoma]]
*[[Large cell carcinoma]]
*[[Adenosquamous lung carcinoma|Adenosquamous carcinoma]]
*[[Sarcomatoid carcinoma of the lung|Sarcomatoid carcinoma]]
*[[Carcinoid]] tumor
*[[Salivary gland-like carcinoma of the lung|Salivary gland-like carcinoma]]

EMECL is considered a subtype of salivary gland-like carcinoma, tumors so named because their histological appearance and characteristics closely resemble malignant neoplasms arising in the major and minor [[salivary glands]].

==Incidence==
EMECL is extremely rare, with only a handful of cases reported in the literature<ref name='DogonayBilgi'>{{cite journal |author=Doganay L, Bilgi S, Ozdil A, Yoruk Y, Altaner S, Kutlu K |title=Epithelial-myoepithelial carcinoma of the lung. A case report and review of the literature |journal=Arch. Pathol. Lab. Med. |volume=127 |issue=4 |pages=e177–80 |year=2003 |month=April |pmid=12683896 |doi=10.1043/0003-9985(2003)127<e177:ECOTL>2.0.CO;2 |url=http://www.archivesofpathology.org/doi/full/10.1043/0003-9985(2003)127<e177:ECOTL>2.0.CO;2}}</ref><ref name='pubmed'>http://www.pubmed.com</ref>

In the lung, two salivary gland-like carcinomas, [[mucoepidermoid carcinoma]] and [[adenoid cystic carcinoma]], while extremely uncommon, occur far more often than does EMECL.<ref name="who2004"/><ref name='TravisTravis'>{{cite journal |author=Travis WD, Travis LB, Devesa SS |title=Lung cancer |journal=Cancer |volume=75 |issue=1 Suppl |pages=191–202 |year=1995 |month=January |pmid=8000996 |doi=10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y}}</ref>

==Histogenesis==
{{Empty section|date=July 2010}}

==Genetics==

The epithelial component in EMECL's typically strongly express [[cytokeratin]]s, but are negative for [[actin]] and [[S-100 protein]], while the myoepithelial component is stains strongly for actin and S-100 protein, and only focally weakly for cytokeratins.<ref name='NguyenSuster'>{{cite journal |author=Nguyen CV, Suster S, Moran CA |title=Pulmonary epithelial-myoepithelial carcinoma: a clinicopathologic and immunohistochemical study of 5 cases |journal=Hum. Pathol. |volume=40 |issue=3 |pages=366–73 |year=2009 |month=March |pmid=18973918 |doi=10.1016/j.humpath.2008.08.009 |url=http://linkinghub.elsevier.com/retrieve/pii/S0046-8177(08)00384-5}}</ref>

==Diagnosis==
Microscopically, EMECL features bi-layered glandular or ductular structures consisting of inner [[cuboidal cells]] and outer [[multipolar cells]].<ref name='OkudelaYazawa'>{{cite journal |author=Okudela K, Yazawa T, Tajiri M, ''et al.'' |title=A case of epithelial-myoepithelial carcinoma of the bronchus - a review of reported cases and a comparison with other salivary gland-type carcinomas of the bronchus |journal=Pathol. Res. Pract. |volume=206 |issue=2 |pages=121–9 |year=2010 |month=February |pmid=19369010 |doi=10.1016/j.prp.2009.03.003 |url=http://linkinghub.elsevier.com/retrieve/pii/S0344-0338(09)00089-2}}</ref>

The histologic appearance of these tumors varied, but all shared the common feature of a biphasic proliferation of [[epithelial cell|epithelial]] (strong cytokeratin-positive; actin and S-100-negative) and [[myoepithelial cell|myoepithelial]] (strong actin and S-100 and focal weak cytokeratin-positive) cells with formation of bilayered ductlike structures. The focal resemblance to other salivary gland-type tumors may cause diagnostic difficulties, particularly in small endobronchial biopsies. Although little is known about their biologic potential due to limited follow-up data, these tumors when in the lung clearly have the capacity to infiltrate and [[metastasis|metastasize]] and therefore should be designated as epithelial-myoepithelial carcinoma. At present, it appears that treatment by complete surgical resection with negative margins alone is appropriate and adequate.<ref name="NguyenSuster"/>

==Staging==
EMECL is staged in the same manner as other non-small cell lung carcinomas, based on the TNM (Tumor-Node-Metastasis) [[TNM staging system|staging system]].<ref>{{cite journal |author=Rami-Porta R, Crowley JJ, Goldstraw P |title=The revised TNM staging system for lung cancer |journal=Ann Thorac Cardiovasc Surg |volume=15 |issue=1 |pages=4–9 |year=2009 |month=February |pmid=19262443 }}</ref>

==Treatment==
Complete radical [[surgical resection]] is the treatment of choice for EMECL, and in most cases, results in long-term survival or cure.<ref name='MuroYoshioka'>{{cite journal |author=Muro M, Yoshioka T, Idani H, ''et al.'' |title=[Epithelial-myoepithelial carcinoma of the lung] |language=Japanese |journal=Kyobu Geka |volume=63 |issue=3 |pages=220–3 |year=2010 |month=March |pmid=20214352 |url=http://www.pieronline.jp/openurl?issn=0021-5252&volume=63&issue=3&spage=220}}</ref><ref>{{cite journal|last=Nishihara|first=Masamitsu|title=Skull Metastasis as Initial Manifestation of Pulmonary Epithelial-Myoepithelial Carcinoma: A Case Report of an Unusual Case|journal=Case Reports in Oncological Medicine|year=2011|doi=10.1155/2011/610383}}</ref>

==Prognosis and Survival==
The prognosis of EMECL is relatively good, and considerably better than most other forms of NSCLC. The skull and dura are possible sites for metastasis from pulmonary EMC. The MIB-1 index is a predictive marker of malignant potential.

==References==
<!--- See [[Wikipedia:Footnotes]] on how to create references using <ref></ref> tags which will then appear here automatically -->
{{Reflist}}

==External links==
*{{cite web |title=Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart |work=World Health Organization Classification of Tumours |url=http://www.iarc.fr/en/publications/pdfs-online/pat-gen/index.php}} (Download Page).
* [http://www.pubmed.com] National Library of Medicine
*{{cite web |title=Lung cancer page  |publisher=National Cancer Institute |url=http://www.cancer.gov/cancertopics/types/lung}}

{{Respiratory neoplasia}}

{{DEFAULTSORT:Epithelial-Myoepithelial Carcinoma Of The Lung}}
[[Category:Rare cancers]]
[[Category:Lung cancer]]